Monoclonal antibodies for septic shock: in or out of the barn door?
Nash
D B
DB
Thomas Jefferson University Hospital, Philadelphia, PA 19107-5099.
Johnson
N E
NE
Gottlieb
J E
JE
Vlasses
P H
PH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016470:Bacteremia / Q000191:economics* / Q000401:mortality / Q000628:therapy; D014487:Centers for Medicare and Medicaid Services, U.S.; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D003953:Diagnosis-Related Groups; D016527:Drug Costs; D004363:Drug Utilization / Q000191:economics / Q000592:standards*; D016905:Gram-Negative Bacterial Infections / Q000191:economics* / Q000401:mortality / Q000628:therapy; D006746:Hospital Bed Capacity, 500 and over; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D015143:Philadelphia; D012051:Reimbursement Mechanisms; D012772:Shock, Septic / Q000191:economics* / Q000401:mortality / Q000628:therapy; D014481:United States
D000911:Antibodies, Monoclonal